Global Treatment of Parathyroid Disease Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 114
Published Date: 19 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Treatment of Parathyroid Disease market size was valued at USD 1289.3 million in 2023 and is forecast to a readjusted size of USD 1933.7 million by 2030 with a CAGR of 6.0% during review period.
The parathyroid glands are four small glands located in the neck that produce parathyroid hormone (PTH), which regulates the levels of calcium and phosphorus in the body. There are several drugs that can affect the function of the parathyroid gland or the levels of PTH in the body.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Treatment of Parathyroid Disease industry chain, the market status of Hospital (Calcitriol, Alfacalcidol), Clinic (Calcitriol, Alfacalcidol), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Treatment of Parathyroid Disease.
Regionally, the report analyzes the Treatment of Parathyroid Disease markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Treatment of Parathyroid Disease market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Treatment of Parathyroid Disease market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Treatment of Parathyroid Disease industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Calcitriol, Alfacalcidol).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Treatment of Parathyroid Disease market.
Regional Analysis: The report involves examining the Treatment of Parathyroid Disease market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Treatment of Parathyroid Disease market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Treatment of Parathyroid Disease:
Company Analysis: Report covers individual Treatment of Parathyroid Disease manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Treatment of Parathyroid Disease This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Treatment of Parathyroid Disease. It assesses the current state, advancements, and potential future developments in Treatment of Parathyroid Disease areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Treatment of Parathyroid Disease market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Treatment of Parathyroid Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Calcitriol
Alfacalcidol
Salmon Calcitonin
Paricalcitol
Other
Market segment by Application
Hospital
Clinic
Other
Major players covered
CTTQ
Roche
Future Health Pharma
KPC Pharmaceuticals
Teva Pharmaceutical
Nantong Huashan Pharmaceutical
Teijin Pharma
Kyowa Kirin
Cheplapharm Arzneimittel
Jiangsu Hengrui Pharmaceuticals
Novartis
Chongqing Yaoyou Pharmaceutical
AbbVie
Hebei Renhe Yikang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Treatment of Parathyroid Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Treatment of Parathyroid Disease, with price, sales, revenue and global market share of Treatment of Parathyroid Disease from 2019 to 2024.
Chapter 3, the Treatment of Parathyroid Disease competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Treatment of Parathyroid Disease breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Treatment of Parathyroid Disease market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Treatment of Parathyroid Disease.
Chapter 14 and 15, to describe Treatment of Parathyroid Disease sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Treatment of Parathyroid Disease
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Treatment of Parathyroid Disease Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Calcitriol
1.3.3 Alfacalcidol
1.3.4 Salmon Calcitonin
1.3.5 Paricalcitol
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Treatment of Parathyroid Disease Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Treatment of Parathyroid Disease Market Size & Forecast
1.5.1 Global Treatment of Parathyroid Disease Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Treatment of Parathyroid Disease Sales Quantity (2019-2030)
1.5.3 Global Treatment of Parathyroid Disease Average Price (2019-2030)
2.1 CTTQ
2.1.1 CTTQ Details
2.1.2 CTTQ Major Business
2.1.3 CTTQ Treatment of Parathyroid Disease Product and Services
2.1.4 CTTQ Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 CTTQ Recent Developments/Updates
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Treatment of Parathyroid Disease Product and Services
2.2.4 Roche Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Recent Developments/Updates
2.3 Future Health Pharma
2.3.1 Future Health Pharma Details
2.3.2 Future Health Pharma Major Business
2.3.3 Future Health Pharma Treatment of Parathyroid Disease Product and Services
2.3.4 Future Health Pharma Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Future Health Pharma Recent Developments/Updates
2.4 KPC Pharmaceuticals
2.4.1 KPC Pharmaceuticals Details
2.4.2 KPC Pharmaceuticals Major Business
2.4.3 KPC Pharmaceuticals Treatment of Parathyroid Disease Product and Services
2.4.4 KPC Pharmaceuticals Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 KPC Pharmaceuticals Recent Developments/Updates
2.5 Teva Pharmaceutical
2.5.1 Teva Pharmaceutical Details
2.5.2 Teva Pharmaceutical Major Business
2.5.3 Teva Pharmaceutical Treatment of Parathyroid Disease Product and Services
2.5.4 Teva Pharmaceutical Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Teva Pharmaceutical Recent Developments/Updates
2.6 Nantong Huashan Pharmaceutical
2.6.1 Nantong Huashan Pharmaceutical Details
2.6.2 Nantong Huashan Pharmaceutical Major Business
2.6.3 Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Product and Services
2.6.4 Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Nantong Huashan Pharmaceutical Recent Developments/Updates
2.7 Teijin Pharma
2.7.1 Teijin Pharma Details
2.7.2 Teijin Pharma Major Business
2.7.3 Teijin Pharma Treatment of Parathyroid Disease Product and Services
2.7.4 Teijin Pharma Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Teijin Pharma Recent Developments/Updates
2.8 Kyowa Kirin
2.8.1 Kyowa Kirin Details
2.8.2 Kyowa Kirin Major Business
2.8.3 Kyowa Kirin Treatment of Parathyroid Disease Product and Services
2.8.4 Kyowa Kirin Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Kyowa Kirin Recent Developments/Updates
2.9 Cheplapharm Arzneimittel
2.9.1 Cheplapharm Arzneimittel Details
2.9.2 Cheplapharm Arzneimittel Major Business
2.9.3 Cheplapharm Arzneimittel Treatment of Parathyroid Disease Product and Services
2.9.4 Cheplapharm Arzneimittel Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Cheplapharm Arzneimittel Recent Developments/Updates
2.10 Jiangsu Hengrui Pharmaceuticals
2.10.1 Jiangsu Hengrui Pharmaceuticals Details
2.10.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.10.3 Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Product and Services
2.10.4 Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business
2.11.3 Novartis Treatment of Parathyroid Disease Product and Services
2.11.4 Novartis Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Novartis Recent Developments/Updates
2.12 Chongqing Yaoyou Pharmaceutical
2.12.1 Chongqing Yaoyou Pharmaceutical Details
2.12.2 Chongqing Yaoyou Pharmaceutical Major Business
2.12.3 Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Product and Services
2.12.4 Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
2.13 AbbVie
2.13.1 AbbVie Details
2.13.2 AbbVie Major Business
2.13.3 AbbVie Treatment of Parathyroid Disease Product and Services
2.13.4 AbbVie Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 AbbVie Recent Developments/Updates
2.14 Hebei Renhe Yikang Pharmaceutical
2.14.1 Hebei Renhe Yikang Pharmaceutical Details
2.14.2 Hebei Renhe Yikang Pharmaceutical Major Business
2.14.3 Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Product and Services
2.14.4 Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Hebei Renhe Yikang Pharmaceutical Recent Developments/Updates
3.1 Global Treatment of Parathyroid Disease Sales Quantity by Manufacturer (2019-2024)
3.2 Global Treatment of Parathyroid Disease Revenue by Manufacturer (2019-2024)
3.3 Global Treatment of Parathyroid Disease Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Treatment of Parathyroid Disease by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Treatment of Parathyroid Disease Manufacturer Market Share in 2023
3.4.2 Top 6 Treatment of Parathyroid Disease Manufacturer Market Share in 2023
3.5 Treatment of Parathyroid Disease Market: Overall Company Footprint Analysis
3.5.1 Treatment of Parathyroid Disease Market: Region Footprint
3.5.2 Treatment of Parathyroid Disease Market: Company Product Type Footprint
3.5.3 Treatment of Parathyroid Disease Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Treatment of Parathyroid Disease Market Size by Region
4.1.1 Global Treatment of Parathyroid Disease Sales Quantity by Region (2019-2030)
4.1.2 Global Treatment of Parathyroid Disease Consumption Value by Region (2019-2030)
4.1.3 Global Treatment of Parathyroid Disease Average Price by Region (2019-2030)
4.2 North America Treatment of Parathyroid Disease Consumption Value (2019-2030)
4.3 Europe Treatment of Parathyroid Disease Consumption Value (2019-2030)
4.4 Asia-Pacific Treatment of Parathyroid Disease Consumption Value (2019-2030)
4.5 South America Treatment of Parathyroid Disease Consumption Value (2019-2030)
4.6 Middle East and Africa Treatment of Parathyroid Disease Consumption Value (2019-2030)
5.1 Global Treatment of Parathyroid Disease Sales Quantity by Type (2019-2030)
5.2 Global Treatment of Parathyroid Disease Consumption Value by Type (2019-2030)
5.3 Global Treatment of Parathyroid Disease Average Price by Type (2019-2030)
6.1 Global Treatment of Parathyroid Disease Sales Quantity by Application (2019-2030)
6.2 Global Treatment of Parathyroid Disease Consumption Value by Application (2019-2030)
6.3 Global Treatment of Parathyroid Disease Average Price by Application (2019-2030)
7.1 North America Treatment of Parathyroid Disease Sales Quantity by Type (2019-2030)
7.2 North America Treatment of Parathyroid Disease Sales Quantity by Application (2019-2030)
7.3 North America Treatment of Parathyroid Disease Market Size by Country
7.3.1 North America Treatment of Parathyroid Disease Sales Quantity by Country (2019-2030)
7.3.2 North America Treatment of Parathyroid Disease Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Treatment of Parathyroid Disease Sales Quantity by Type (2019-2030)
8.2 Europe Treatment of Parathyroid Disease Sales Quantity by Application (2019-2030)
8.3 Europe Treatment of Parathyroid Disease Market Size by Country
8.3.1 Europe Treatment of Parathyroid Disease Sales Quantity by Country (2019-2030)
8.3.2 Europe Treatment of Parathyroid Disease Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Treatment of Parathyroid Disease Market Size by Region
9.3.1 Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Treatment of Parathyroid Disease Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Treatment of Parathyroid Disease Sales Quantity by Type (2019-2030)
10.2 South America Treatment of Parathyroid Disease Sales Quantity by Application (2019-2030)
10.3 South America Treatment of Parathyroid Disease Market Size by Country
10.3.1 South America Treatment of Parathyroid Disease Sales Quantity by Country (2019-2030)
10.3.2 South America Treatment of Parathyroid Disease Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Treatment of Parathyroid Disease Market Size by Country
11.3.1 Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Treatment of Parathyroid Disease Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Treatment of Parathyroid Disease Market Drivers
12.2 Treatment of Parathyroid Disease Market Restraints
12.3 Treatment of Parathyroid Disease Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Treatment of Parathyroid Disease and Key Manufacturers
13.2 Manufacturing Costs Percentage of Treatment of Parathyroid Disease
13.3 Treatment of Parathyroid Disease Production Process
13.4 Treatment of Parathyroid Disease Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Treatment of Parathyroid Disease Typical Distributors
14.3 Treatment of Parathyroid Disease Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Treatment of Parathyroid Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Treatment of Parathyroid Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CTTQ Basic Information, Manufacturing Base and Competitors
Table 4. CTTQ Major Business
Table 5. CTTQ Treatment of Parathyroid Disease Product and Services
Table 6. CTTQ Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CTTQ Recent Developments/Updates
Table 8. Roche Basic Information, Manufacturing Base and Competitors
Table 9. Roche Major Business
Table 10. Roche Treatment of Parathyroid Disease Product and Services
Table 11. Roche Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Roche Recent Developments/Updates
Table 13. Future Health Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Future Health Pharma Major Business
Table 15. Future Health Pharma Treatment of Parathyroid Disease Product and Services
Table 16. Future Health Pharma Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Future Health Pharma Recent Developments/Updates
Table 18. KPC Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. KPC Pharmaceuticals Major Business
Table 20. KPC Pharmaceuticals Treatment of Parathyroid Disease Product and Services
Table 21. KPC Pharmaceuticals Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. KPC Pharmaceuticals Recent Developments/Updates
Table 23. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Major Business
Table 25. Teva Pharmaceutical Treatment of Parathyroid Disease Product and Services
Table 26. Teva Pharmaceutical Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Teva Pharmaceutical Recent Developments/Updates
Table 28. Nantong Huashan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Nantong Huashan Pharmaceutical Major Business
Table 30. Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Product and Services
Table 31. Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Nantong Huashan Pharmaceutical Recent Developments/Updates
Table 33. Teijin Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Teijin Pharma Major Business
Table 35. Teijin Pharma Treatment of Parathyroid Disease Product and Services
Table 36. Teijin Pharma Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Teijin Pharma Recent Developments/Updates
Table 38. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
Table 39. Kyowa Kirin Major Business
Table 40. Kyowa Kirin Treatment of Parathyroid Disease Product and Services
Table 41. Kyowa Kirin Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Kyowa Kirin Recent Developments/Updates
Table 43. Cheplapharm Arzneimittel Basic Information, Manufacturing Base and Competitors
Table 44. Cheplapharm Arzneimittel Major Business
Table 45. Cheplapharm Arzneimittel Treatment of Parathyroid Disease Product and Services
Table 46. Cheplapharm Arzneimittel Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Cheplapharm Arzneimittel Recent Developments/Updates
Table 48. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Jiangsu Hengrui Pharmaceuticals Major Business
Table 50. Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Product and Services
Table 51. Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 53. Novartis Basic Information, Manufacturing Base and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Treatment of Parathyroid Disease Product and Services
Table 56. Novartis Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Novartis Recent Developments/Updates
Table 58. Chongqing Yaoyou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Chongqing Yaoyou Pharmaceutical Major Business
Table 60. Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Product and Services
Table 61. Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
Table 63. AbbVie Basic Information, Manufacturing Base and Competitors
Table 64. AbbVie Major Business
Table 65. AbbVie Treatment of Parathyroid Disease Product and Services
Table 66. AbbVie Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. AbbVie Recent Developments/Updates
Table 68. Hebei Renhe Yikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Hebei Renhe Yikang Pharmaceutical Major Business
Table 70. Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Product and Services
Table 71. Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Hebei Renhe Yikang Pharmaceutical Recent Developments/Updates
Table 73. Global Treatment of Parathyroid Disease Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 74. Global Treatment of Parathyroid Disease Revenue by Manufacturer (2019-2024) & (USD Million)
Table 75. Global Treatment of Parathyroid Disease Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 76. Market Position of Manufacturers in Treatment of Parathyroid Disease, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 77. Head Office and Treatment of Parathyroid Disease Production Site of Key Manufacturer
Table 78. Treatment of Parathyroid Disease Market: Company Product Type Footprint
Table 79. Treatment of Parathyroid Disease Market: Company Product Application Footprint
Table 80. Treatment of Parathyroid Disease New Market Entrants and Barriers to Market Entry
Table 81. Treatment of Parathyroid Disease Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Treatment of Parathyroid Disease Sales Quantity by Region (2019-2024) & (K Units)
Table 83. Global Treatment of Parathyroid Disease Sales Quantity by Region (2025-2030) & (K Units)
Table 84. Global Treatment of Parathyroid Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 85. Global Treatment of Parathyroid Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 86. Global Treatment of Parathyroid Disease Average Price by Region (2019-2024) & (US$/Unit)
Table 87. Global Treatment of Parathyroid Disease Average Price by Region (2025-2030) & (US$/Unit)
Table 88. Global Treatment of Parathyroid Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Global Treatment of Parathyroid Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Global Treatment of Parathyroid Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Global Treatment of Parathyroid Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Global Treatment of Parathyroid Disease Average Price by Type (2019-2024) & (US$/Unit)
Table 93. Global Treatment of Parathyroid Disease Average Price by Type (2025-2030) & (US$/Unit)
Table 94. Global Treatment of Parathyroid Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Global Treatment of Parathyroid Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Global Treatment of Parathyroid Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Global Treatment of Parathyroid Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Global Treatment of Parathyroid Disease Average Price by Application (2019-2024) & (US$/Unit)
Table 99. Global Treatment of Parathyroid Disease Average Price by Application (2025-2030) & (US$/Unit)
Table 100. North America Treatment of Parathyroid Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 101. North America Treatment of Parathyroid Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 102. North America Treatment of Parathyroid Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 103. North America Treatment of Parathyroid Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 104. North America Treatment of Parathyroid Disease Sales Quantity by Country (2019-2024) & (K Units)
Table 105. North America Treatment of Parathyroid Disease Sales Quantity by Country (2025-2030) & (K Units)
Table 106. North America Treatment of Parathyroid Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 107. North America Treatment of Parathyroid Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Europe Treatment of Parathyroid Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 109. Europe Treatment of Parathyroid Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 110. Europe Treatment of Parathyroid Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 111. Europe Treatment of Parathyroid Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 112. Europe Treatment of Parathyroid Disease Sales Quantity by Country (2019-2024) & (K Units)
Table 113. Europe Treatment of Parathyroid Disease Sales Quantity by Country (2025-2030) & (K Units)
Table 114. Europe Treatment of Parathyroid Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Europe Treatment of Parathyroid Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 117. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 118. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 119. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 120. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Region (2019-2024) & (K Units)
Table 121. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Region (2025-2030) & (K Units)
Table 122. Asia-Pacific Treatment of Parathyroid Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 123. Asia-Pacific Treatment of Parathyroid Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 124. South America Treatment of Parathyroid Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 125. South America Treatment of Parathyroid Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 126. South America Treatment of Parathyroid Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 127. South America Treatment of Parathyroid Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 128. South America Treatment of Parathyroid Disease Sales Quantity by Country (2019-2024) & (K Units)
Table 129. South America Treatment of Parathyroid Disease Sales Quantity by Country (2025-2030) & (K Units)
Table 130. South America Treatment of Parathyroid Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 131. South America Treatment of Parathyroid Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 132. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 133. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 134. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 135. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 136. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Region (2019-2024) & (K Units)
Table 137. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Region (2025-2030) & (K Units)
Table 138. Middle East & Africa Treatment of Parathyroid Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 139. Middle East & Africa Treatment of Parathyroid Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 140. Treatment of Parathyroid Disease Raw Material
Table 141. Key Manufacturers of Treatment of Parathyroid Disease Raw Materials
Table 142. Treatment of Parathyroid Disease Typical Distributors
Table 143. Treatment of Parathyroid Disease Typical Customers
List of Figures
Figure 1. Treatment of Parathyroid Disease Picture
Figure 2. Global Treatment of Parathyroid Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Treatment of Parathyroid Disease Consumption Value Market Share by Type in 2023
Figure 4. Calcitriol Examples
Figure 5. Alfacalcidol Examples
Figure 6. Salmon Calcitonin Examples
Figure 7. Paricalcitol Examples
Figure 8. Other Examples
Figure 9. Global Treatment of Parathyroid Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Treatment of Parathyroid Disease Consumption Value Market Share by Application in 2023
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Other Examples
Figure 14. Global Treatment of Parathyroid Disease Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Treatment of Parathyroid Disease Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Treatment of Parathyroid Disease Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Treatment of Parathyroid Disease Average Price (2019-2030) & (US$/Unit)
Figure 18. Global Treatment of Parathyroid Disease Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Treatment of Parathyroid Disease Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Treatment of Parathyroid Disease by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Treatment of Parathyroid Disease Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Treatment of Parathyroid Disease Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Treatment of Parathyroid Disease Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Treatment of Parathyroid Disease Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Treatment of Parathyroid Disease Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Treatment of Parathyroid Disease Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Treatment of Parathyroid Disease Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Treatment of Parathyroid Disease Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Treatment of Parathyroid Disease Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Treatment of Parathyroid Disease Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Treatment of Parathyroid Disease Average Price by Type (2019-2030) & (US$/Unit)
Figure 33. Global Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Treatment of Parathyroid Disease Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Treatment of Parathyroid Disease Average Price by Application (2019-2030) & (US$/Unit)
Figure 36. North America Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Treatment of Parathyroid Disease Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Treatment of Parathyroid Disease Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Treatment of Parathyroid Disease Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Treatment of Parathyroid Disease Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Treatment of Parathyroid Disease Consumption Value Market Share by Region (2019-2030)
Figure 56. China Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Treatment of Parathyroid Disease Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Treatment of Parathyroid Disease Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Treatment of Parathyroid Disease Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Treatment of Parathyroid Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Treatment of Parathyroid Disease Market Drivers
Figure 77. Treatment of Parathyroid Disease Market Restraints
Figure 78. Treatment of Parathyroid Disease Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Treatment of Parathyroid Disease in 2023
Figure 81. Manufacturing Process Analysis of Treatment of Parathyroid Disease
Figure 82. Treatment of Parathyroid Disease Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
CTTQ Roche Future Health Pharma KPC Pharmaceuticals Teva Pharmaceutical Nantong Huashan Pharmaceutical Teijin Pharma Kyowa Kirin Cheplapharm Arzneimittel Jiangsu Hengrui Pharmaceuticals Novartis Chongqing Yaoyou Pharmaceutical AbbVie Hebei Renhe Yikang Pharmaceutical
Related Reports
12 Apr 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
